Target intelligence / Profile preview

Leucine zipper and EF-hand containing transmembrane protein 1 pseudogene 2 (LETM1P2)

Target
LETM1P2
Molecular classification
Pseudogene, Long non-coding RNA (lncRNA) (potential, inferred from general pseudogene literature[1][2][7]), Other
01

Overview

Leucine zipper and EF-hand containing transmembrane protein 1 pseudogene 2 (LETM1P2) is a classified pseudogene and not a protein-coding gene. Pseudogenes are genomic elements that resemble functional genes but typically contain mutations preventing them from encoding functional proteins[7]. Like other pseudogenes, LETM1P2 may be transcribed into RNA, potentially participating in regulatory networks, such as acting as microRNA decoys or influencing the stability of related mRNAs, though there is no published evidence for a unique biological or pathological role for LETM1P2 specifically[1][3][6][7]. LETM1P2 is not known to be a therapeutic target, biomarker, or directly druggable molecule. Nor is it considered a receptor, enzyme, transporter, or other typical druggable class[1][3][6][7].

Other names
LETM1 pseudogene 2
02

Biological functions

Regulation of gene expression via decoy or sponge mechanisms (potential, inferred from known roles of pseudogenes)Other
03

Disease associations

Other (no documented direct disease link for LETM1P2; general pseudogenes may be deregulated in cancer and other diseases[1])

Beyond the preview

Go deeper on Leucine zipper and EF-hand containing transmembrane protein 1 pseudogene 2 (LETM1P2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Leucine zipper and EF-hand containing transmembrane protein 1 pseudogene 2 (LETM1P2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call